Pierre Bergmann

2.9k total citations
110 papers, 2.1k citations indexed

About

Pierre Bergmann is a scholar working on Oncology, Nephrology and Molecular Biology. According to data from OpenAlex, Pierre Bergmann has authored 110 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 27 papers in Nephrology and 26 papers in Molecular Biology. Recurrent topics in Pierre Bergmann's work include Bone health and treatments (34 papers), Parathyroid Disorders and Treatments (25 papers) and Bone health and osteoporosis research (20 papers). Pierre Bergmann is often cited by papers focused on Bone health and treatments (34 papers), Parathyroid Disorders and Treatments (25 papers) and Bone health and osteoporosis research (20 papers). Pierre Bergmann collaborates with scholars based in Belgium, United States and Germany. Pierre Bergmann's co-authors include A Heilporn, Ahmed Ismail, Stefan Goemaere, Serge Rozenberg, Jean‐Marc Kaufman, Evelien Gielen, Jean‐Jacques Body, Jacques Corvilain, Jean‐Yves Reginster and Olivier Bruyère and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pierre Bergmann

103 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Bergmann Belgium 27 546 471 455 305 289 110 2.1k
P Bordier France 22 445 0.8× 297 0.6× 415 0.9× 481 1.6× 214 0.7× 87 2.0k
R. Swaminathan United Kingdom 28 456 0.8× 653 1.4× 308 0.7× 566 1.9× 280 1.0× 95 2.8k
Daniel T. Baran United States 26 922 1.7× 549 1.2× 402 0.9× 633 2.1× 324 1.1× 72 2.3k
David B. Endres United States 24 356 0.7× 227 0.5× 246 0.5× 391 1.3× 170 0.6× 36 1.7k
B.E.C. Nordin United Kingdom 25 824 1.5× 241 0.5× 426 0.9× 423 1.4× 224 0.8× 67 1.9k
Richard Keen United Kingdom 31 1.1k 2.0× 673 1.4× 419 0.9× 564 1.8× 370 1.3× 92 2.8k
Aubrey Blumsohn United Kingdom 30 1.4k 2.6× 751 1.6× 772 1.7× 435 1.4× 348 1.2× 68 2.8k
Harold N. Rosen United States 25 1.4k 2.5× 672 1.4× 789 1.7× 344 1.1× 393 1.4× 68 2.6k
Francisco José Albuquerque de Paula Brazil 30 751 1.4× 608 1.3× 324 0.7× 266 0.9× 443 1.5× 148 2.7k
Usha Bava New Zealand 15 563 1.0× 458 1.0× 371 0.8× 285 0.9× 191 0.7× 24 1.6k

Countries citing papers authored by Pierre Bergmann

Since Specialization
Citations

This map shows the geographic impact of Pierre Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bergmann more than expected).

Fields of papers citing papers by Pierre Bergmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bergmann. The network helps show where Pierre Bergmann may publish in the future.

Co-authorship network of co-authors of Pierre Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Bergmann. A scholar is included among the top collaborators of Pierre Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Bergmann. Pierre Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beyer, Ingo, Rose Njemini, Ivan Bautmans, et al.. (2011). Inflammation-related muscle weakness and fatigue in geriatric patients. Experimental Gerontology. 47(1). 52–59. 52 indexed citations
2.
Demulder, Anne, Fleur Wolff, Christian Mélot, et al.. (2010). Osteoprotegerin and Progression of Coronary and Aortic Calcifications in Chronic Kidney Disease. Transplantation Proceedings. 42(9). 3444–3449. 12 indexed citations
3.
Holy, Xavier, et al.. (2007). Decreased PTHrP mRNA expression in the periosteum of hind limb long bones in tail suspended rats. Bone. 40(2). 211. 1 indexed citations
4.
Demulder, Anne, et al.. (2006). OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clinical Biochemistry. 39(6). 617–622. 8 indexed citations
5.
6.
Beyer, Ingo, et al.. (1998). Regulation by 1,25 dihydroxycholecalciferol of Parathyroid Hormone related Peptide messenger RNA in feta rat long bones. Bone. 22. 3. 2 indexed citations
7.
Beyer, Ingo, et al.. (1995). Bone metabolism in idiopathic renal stone formers on a self-selected diet. Bone. 16. 136. 1 indexed citations
8.
Pepersack, Thierry & Pierre Bergmann. (1995). Effect of lithium and hydroxyurea on the escape of bone resorption from calcitonin inhibition. Bone. 16. 167. 2 indexed citations
9.
Brabant, Georg, et al.. (1992). Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism. 41(10). 1093–1096. 56 indexed citations
10.
Pepersack, Thierry, et al.. (1990). Fetal rat long bones contain a cyclase stimulating activity immunologically similar to PTHrP. Calcified Tissue International. 46(2). 56. 1 indexed citations
11.
Bergmann, Pierre, et al.. (1987). The interaction of cationized, serum albumin with adenylate cyclase in canine renal membranes. Calcified Tissue International. 41. 37. 1 indexed citations
12.
Bergmann, Pierre, et al.. (1986). Regional bone mineral In a case of osteopetrosis. Calcified Tissue International. 39. 126. 2 indexed citations
13.
Corvilain, Jacques, et al.. (1984). Cationized human serum albumin Increases parathyroid hormone stimulated cAMP production by renal plasma membranes. Calcified Tissue International. 36. 506. 1 indexed citations
14.
Vanherweghem, Jean‐Louis, André Schoutens, & Pierre Bergmann. (1984). Usefulness of 99mTc pyrophosphate bone scintigraphy in aluminium bone disease. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1(2). 80–83. 5 indexed citations
15.
Karmali, Rafik, C. Gillet, Michel Fuss, et al.. (1984). Parathyroid gland scintigraphy with T1201 in primary hyperparathyroidism. Calcified Tissue International. 36. 9. 1 indexed citations
16.
Fuss, Michel, C. Gillet, Rafik Karmali, et al.. (1983). Calcium metabolism in tuberculosis. Calcified Tissue International. 35. 35. 2 indexed citations
17.
Bergmann, Pierre. (1983). Enhanced response to PTH of fetal rat long bones cultured in the presence of cationized albumin. Calcified Tissue International. 35. 27. 1 indexed citations
18.
Manicourt, D., et al.. (1981). The bone metabolic alteration in joint disease. Calcified Tissue International. 33. 175. 3 indexed citations
19.
Fuss, Michel, et al.. (1978). Corticodependent hypercalcemia in patients under regular dialysis treatment (RDT). Kidney International. 13. 435–436. 3 indexed citations
20.
Bergmann, Pierre, et al.. (1976). Clinical application of whole body counting for studying regional bone calcium turnover. European Journal of Nuclear Medicine and Molecular Imaging. 1(2). 97–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026